Farrokh Modabber

Summary

Publications

  1. ncbi Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis
    Hashim Ghalib
    Centre for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
    Kinetoplastid Biol Dis 6:7. 2007
  2. ncbi Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis
    Ali Khamesipour
    Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, P O Box 14155 6383, Tehran 14166, Iran
    Vaccine 23:3642-8. 2005
  3. ncbi Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis
    Sassan Noazin
    World Health Organization, CH1211, Geneva 27, Switzerland
    Vaccine 27:4747-53. 2009
  4. ncbi Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006
    Iraj Sharifi
    Leishmaniasis Research Center, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
    Int J Dermatol 49:557-61. 2010
  5. ncbi The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis
    Mohammad Hossein Alimohammadian
    Department of Immunology, Pasteur Institute of Iran, Tehran, Iran
    Vaccine 21:174-80. 2002
  6. ncbi Leishmaniasis vaccine candidates for development: a global overview
    Ali Khamesipour
    Center for Research and Training in Skin Disease and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
    Indian J Med Res 123:423-38. 2006

Collaborators

Detail Information

Publications6

  1. ncbi Consultation meeting on the development of therapeutic vaccines for post kala azar dermal leishmaniasis
    Hashim Ghalib
    Centre for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
    Kinetoplastid Biol Dis 6:7. 2007
    ....
  2. ncbi Leishmanization: use of an old method for evaluation of candidate vaccines against leishmaniasis
    Ali Khamesipour
    Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, P O Box 14155 6383, Tehran 14166, Iran
    Vaccine 23:3642-8. 2005
    ..LZ used as live challenge to test vaccine candidates reduces the required sample size, is cost effective for surrogate markers studies and will induce protection in the participants who are not protected by candidate vaccines...
  3. ncbi Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis: a meta-analysis
    Sassan Noazin
    World Health Organization, CH1211, Geneva 27, Switzerland
    Vaccine 27:4747-53. 2009
    ..The findings indicate that the whole-parasite vaccine candidates tested do not confer significant protection against human leishmaniasis...
  4. ncbi Leishmaniasis recidivans among school children in Bam, South-east Iran, 1994-2006
    Iraj Sharifi
    Leishmaniasis Research Center, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
    Int J Dermatol 49:557-61. 2010
    ..Leishmaniasis recidivans (LR) is a rare phenomenon in the world with high morbidity in children...
  5. ncbi The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis
    Mohammad Hossein Alimohammadian
    Department of Immunology, Pasteur Institute of Iran, Tehran, Iran
    Vaccine 21:174-80. 2002
    ..Three injections of BCG produced no observable adverse reaction; hence BCG could be used in booster injections to increase the protective potential of this candidate vaccine...
  6. ncbi Leishmaniasis vaccine candidates for development: a global overview
    Ali Khamesipour
    Center for Research and Training in Skin Disease and Leprosy, Tehran University of Medical Sciences, Tehran, Iran
    Indian J Med Res 123:423-38. 2006
    ..This is not an exhaustive review of vaccine discovery or the principles of clinical immunology underlying vaccine development...